share_log

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth

CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth

CBD生命科學公司(CBDL)獲得沃爾瑪市場針對蘑菇補充品的突破性批准,爲前所未有的增長奠定了基礎。
Accesswire ·  01/07 21:00

Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line.

沃爾瑪市場的成交量同比增長了60%,第三方賣家佔在線銷售的50%以上,使得沃爾瑪的電子商務營業收入在2024年超過了1000億。這使其成爲快速品牌增長的強大平台,也是CBDL突破性產品線的改變遊戲規則的機會。

SCOTTSDALE, ARIZONA / ACCESSWIRE / January 7, 2025 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in wellness innovation, is thrilled to announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market.

亞利桑那州斯科茨代爾 / ACCESSWIRE / 2025年1月7日 / CBD Life Sciences, Inc. (場外交易 PINK:CBDL),作爲健康創新的領軍者,欣然宣佈其蘑菇瘋狂提神軟糖正式獲得銷售批准,並現已在沃爾瑪市場上線。這個重要的批准爲CBDL開闢了進入沃爾瑪龐大電子商務生態系統的機會,爲可觀的營業收入增長提供了途徑,同時增強了其在快速擴張的功能性蘑菇市場中的地位。

Expanding Market Potential

擴展市場潛力

The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions.

全球功能性蘑菇市場持續增長,預計到2028年將達到424億,獅子鬃蘑菇產品因其認知健康益處而引領潮流。CBDL的蘑菇瘋狂提神軟糖,旨在提高專注力、清晰度和增強心理表現,正好滿足日益增長的天然健康解決方案需求。

Lisa Nelson, President and CEO of CBDL, commented on this milestone:
"This approval is more than just an entry into Walmart-it's a strategic step toward scaling our operations and driving significant shareholder value. We're not only gaining access to millions of health-conscious consumers but also leveraging Walmart's trusted platform to amplify our brand's reach and credibility."

CBDL的總裁兼首席執行官麗莎·尼爾森對此里程碑發表了評價:
「這個批准不僅僅是進入沃爾瑪的機會,這是我們擴展運營和推動顯著股東價值的策略一步。我們不僅能接觸到數百萬關注健康的消費者,還能利用沃爾瑪可信賴的平台來擴大我們的品牌影響力和信譽。」

The Walmart Marketplace Advantage

沃爾瑪市場的優勢

Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base.

沃爾瑪市場被公認爲是增長最快的在線零售平台之一,每月擁有超過10000萬的訪客。第三方賣家爲沃爾瑪的電子商務營業收入創造了可觀的部分,該平台爲新興品牌提供了無與倫比的擴展性和可見性。CBDL進入沃爾瑪市場提供了物流高效性、增強的消費者信任以及與一個龐大、不斷擴展的客戶群體的直接聯繫。

Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network.

行業報告顯示,第三方賣家在沃爾瑪市場上線數月內通常會經歷雙位數的銷售增長。這爲CBDL提供了前所未有的機會,快速擴大其營業收入,更進一步得到沃爾瑪強大的數字營銷支持和履約網絡的助力。

Revenue Impact and Growth Strategy

營業收入影響與增長策略

CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements.

CBD生命科學自2024年2月以來已經實現了令人印象深刻的財務增長,營業收入增長了1405.46%。公司預計沃爾瑪市場將顯著增強其營業收入來源,鑑於功能性蘑菇產品和CBD注入補充品的快速消費採用。

The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry.

蘑菇瘋狂升起糖果是CBDL產品系列中的戰略性補充,與公司致力於提供科學配方、高效能的健康產品的承諾相一致。這些糖果不僅滿足了日益增長的健康市場,還使CBDL有望在價值200億的美國補充品行業中佔據重要份額。

As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.

作爲其長期策略的一部分,CBDL計劃在沃爾瑪市場推出更多熱銷產品,包括備受期待的納米CBD補充品和蘑菇增強型營養粉。

Commitment to Shareholders

對股東的承諾

CBDL remains steadfast in its mission to drive long-term shareholder value by continuously expanding into high-growth markets. The Walmart Marketplace approval is expected to further strengthen investor confidence, positioning the company as a market leader in innovative health solutions. With an expanding portfolio of products and a growing number of retail partnerships, CBDL is on track to deliver sustained financial growth and operational excellence.

CBDL堅定致力於通過不斷擴展至高增長市場來推動長期股東價值。沃爾瑪市場的批准預計將進一步增強投資者信心,使公司在創新健康解決方案領域處於市場領先地位。隨着產品組合的擴大和零售夥伴關係的增加,CBDL正朝着持續財務增長和運營卓越的軌道前進。

Customers can purchase the product directly by visiting this link:

客戶可以通過訪問該鏈接直接購買產品:

About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC:CBDL) is a pioneering health and wellness company specializing in high-quality CBD products and functional supplements. With a focus on innovation, the company leverages advanced technology and scientific research to develop effective solutions that promote overall well-being. CBDL's diverse product range includes nano-enhanced CBD creamers, pain relief creams, and functional mushroom blends.

關於CBD生命科學公司
CBD生命科學公司(場外交易:CBDL)是一家開創性的健康和保健公司,專注於高質量的CBD產品和功能性補充劑。公司注重創新,利用愛文思控股技術和科學研究開發出促進整體健康的有效解決方案。CBDL的多樣化產品區間包括納米增強型CBD奶精、痛症緩解霜和功能性蘑菇混合物。

For more information about CBD Life Sciences, Inc. and its product offerings, visit

有關CBD生命科學公司及其產品的信息,請訪問

Follow our social media for the latest updates!

關注我們的社交媒體獲取最新動態!

X:
Instagram:
IR Contact: cbdvaultaz@gmail.com

X:
Instagram:
IR聯繫方式: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

前瞻性聲明
除了此文中包含的歷史信息外,本新聞稿所討論的事項均爲前瞻性聲明。實際結果可能與前瞻性聲明中描述的結果存在重大差異,並且可能會受到風險和不確定性的影響。請參閱 CBD Life Sciences, Inc. 的 OTC Markets 提交的文件,其中可能指出可能導致實際結果或事件與前瞻性聲明中描述的結果存在重大差異的具體因素。

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

安全港聲明
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

聯繫信息
Lisa Nelson
首席執行官
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.

來源:CBD生命科學公司


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論